Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis

In this study (trial registration: NCT02166021), we aimed to evaluate the optimal way of administration, the safety and the clinical efficacy of mesenchymal stem cell (MSC) transplantation in patients with active and progressive multiple sclerosis. Forty-eight patients (28 males and 20 females) with...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Brain (London, England : 1878) Jg. 143; H. 12; S. 3574
Hauptverfasser:	Petrou, Panayiota, Kassis, Ibrahim, Levin, Netta, Paul, Friedemann, Backner, Yael, Benoliel, Tal, Oertel, Frederike Cosima, Scheel, Michael, Hallimi, Michelle, Yaghmour, Nour, Hur, Tamir Ben, Ginzberg, Ariel, Levy, Yarden, Abramsky, Oded, Karussis, Dimitrios
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England 01.12.2020
Schlagworte:	Adult Brain - diagnostic imaging Disease Progression Double-Blind Method Endpoint Determination Female Follow-Up Studies Humans Injections, Intravenous Injections, Spinal Magnetic Resonance Imaging Male Mesenchymal Stem Cell Transplantation - adverse effects Mesenchymal Stem Cell Transplantation - methods Middle Aged Multiple Sclerosis - diagnostic imaging Multiple Sclerosis - psychology Multiple Sclerosis - therapy Multiple Sclerosis, Chronic Progressive - therapy Neuropsychological Tests Recurrence Tomography, Optical Coherence Treatment Outcome Walking stem cells neuro-regeneration mesenchymal stromal cells (MSC) multiple sclerosis neuroprotection
ISSN:	1460-2156, 1460-2156
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!